1887

Abstract

Vaccinia virus produces several forms of infectious virions. Intracellular mature virions (IMV) assemble in areas close to the cell nucleus. Some IMV acquire an envelope from intracellular membranes derived from the trans-Golgi network, producing enveloped forms found in the cytosol (intracellular enveloped virus; IEV), on the cell surface (cell-associated enveloped virus) or free in the medium (extracellular enveloped virus; EEV). Blockage of IMV envelopment inhibits transport of virions to the cell surface, indicating that enveloped virus forms are required for virion movement from the Golgi area. To date, the induction of actin tails that propel IEV is the only well-characterized mechanism for enveloped virus transport. However, enveloped virus transport and release occur under conditions where actin tails are not formed. In order to study these events, recombinant vaccinia viruses were constructed with GFP fused to the most abundant protein in the EEV envelope, P37 (F13L). The P37–GFP fusion, like normal P37, accumulated in the Golgi area and was incorporated efficiently into enveloped virions. These recombinants allowed the monitoring of enveloped virus movements . In addition to a variety of relatively slow movements (<0·4 μm/s), faster, saltatory movements both towards and away from the Golgi area were observed. These movements were different from those dependent on actin tails and were inhibited by the microtubule-disrupting drug nocodazole, but not by the myosin inhibitor 2,3-butanedione monoxime. Video microscopy (5 frames per s) revealed that saltatory movements had speeds of up to, and occasionally more than, 3 μm/s. These results suggest that a second, microtubule-dependent mechanism exists for intracellular transport of enveloped vaccinia virions.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-11-2747
2001-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/11/0822747a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-11-2747&mimeType=html&fmt=ahah

References

  1. Blasco R., Moss B. 1991; Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. Journal of Virology 65:5910–5920
    [Google Scholar]
  2. Blasco R., Moss B. 1992; Role of cell-associated enveloped vaccinia virus in cell-to-cell virus spread. Journal of Virology 66:4170–4179
    [Google Scholar]
  3. Blasco R., Moss B. 1995; Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157–162
    [Google Scholar]
  4. Cudmore S., Cossart P., Griffiths G., Way M. 1995; Actin-based motility of vaccinia virus. Nature 378:636–638
    [Google Scholar]
  5. Cudmore S., Reckmann I., Griffiths G., Way M. 1996; Vaccinia virus: a model system for actin–membrane interactions. Journal of Cell Science 109:1739–1747
    [Google Scholar]
  6. Cudmore S., Reckmann I., Way M. 1997; Viral manipulations of the actin cytoskeleton. Trends in Microbiology 5:142–148
    [Google Scholar]
  7. Earl P., Moss B. 1991 Expression of proteins in mammalian cells using vaccinia viral vectors. In Current Protocols in Molecular Biology , section IV, units 16.15–16.19 Edited by Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. New York: Wiley;
    [Google Scholar]
  8. Frischknecht F., Cudmore S., Moreau V., Reckmann I., Rottger S., Way M. 1999a; Tyrosine phosphorylation is required for actin-based motility of vaccinia but not Listeria or Shigella. Current Biology 9:89–92
    [Google Scholar]
  9. Frischknecht F., Moreau V., Rottger S., Gonfloni S., Reckmann I., Superti-Furga G., Way M. 1999b; Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926–929
    [Google Scholar]
  10. Goode B. L., Drubin D. G., Barnes G. 2000; Functional cooperation between the microtubule and actin cytoskeletons. Current Opinion in Cell Biology 12:63–71
    [Google Scholar]
  11. Herrera E., del Mar Lorenzo M., Blasco R., Isaacs S. N. 1998; Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. Journal of Virology 72:294–302
    [Google Scholar]
  12. Higuchi H., Takemori S. 1989; Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle. Journal of Biochemistry 105:638–643
    [Google Scholar]
  13. Hiller G., Weber K. 1985; Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. Journal of Virology 55:651–659
    [Google Scholar]
  14. Hiller G., Weber K., Schneider L., Parajsz C., Jungwirth C. 1979; Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98:142–153
    [Google Scholar]
  15. Hiller G., Eibl H., Weber K. 1981; Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release. Journal of Virology 39:903–913
    [Google Scholar]
  16. Hirschberg K., Miller C. M., Ellenberg J., Presley J. F., Siggia E. D., Phair R. D., Lippincott-Schwartz J. 1998; Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. Journal of Cell Biology 143:1485–1503
    [Google Scholar]
  17. Kato N., Eggers H. J., Rolly H. 1969; Inhibition of release of vaccinia virus by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. Journal of Experimental Medicine 129:795–808
    [Google Scholar]
  18. Kreitzer G., Marmorstein A., Okamoto P., Vallee R., Rodriguez-Boulan E. 2000; Kinesin and dynamin are required for post-Golgi transport of a plasma-membrane protein. Nature Cell Biology 2:125–127
    [Google Scholar]
  19. Lippincott-Schwartz J., Roberts T. H., Hirschberg K. 2000; Secretory protein trafficking and organelle dynamics in living cells. Annual Review of Cell and Developmental Biology 16:557–589
    [Google Scholar]
  20. Lorenzo M. M., Blasco R. 1998; PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus. Biotechniques 24:308–313
    [Google Scholar]
  21. Lorenzo M. M., Galindo I., Griffiths G., Blasco R. 2000; Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. Journal of Virology 74:10535–10550
    [Google Scholar]
  22. McKillop D. F., Fortune N. S., Ranatunga K. W., Geeves M. A. 1994; The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres. Journal of Muscle Research and Cell Motility 15:309–318
    [Google Scholar]
  23. Mathew E., Sanderson C. M., Hollinshead M., Smith G. L. 1998; The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. Journal of Virology 72:2429–2438
    [Google Scholar]
  24. Moss B. 1996; Poxviridae : the viruses and their replication. In Fields Virology pp 2637–2671 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  25. Payne L. G., Kristenson K. 1979; Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. Journal of Virology 32:614–622
    [Google Scholar]
  26. Ploubidou A., Moreau V., Ashman K., Reckmann I., Gonzalez C., Way M. 2000; Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO Journal 19:3932–3944
    [Google Scholar]
  27. Rodriguez J. F., Smith G. L. 1990; IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Research 18:5347–5351
    [Google Scholar]
  28. Rogers S. L., Gelfand V. I. 2000; Membrane trafficking, organelle transport, and the cytoskeleton. Current Opinion in Cell Biology 12:57–62
    [Google Scholar]
  29. Sanchez-Puig J. M., Blasco R. 2000; Puromycin resistance ( pac ) gene as a selectable marker in vaccinia virus. Gene 257:57–65
    [Google Scholar]
  30. Sanderson C. M., Frischknecht F., Way M., Hollinshead M., Smith G. L. 1998; Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell–cell fusion. Journal of General Virology 79:1415–1425
    [Google Scholar]
  31. Sanderson C. M., Hollinshead M., Smith G. L. 2000; The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. Journal of General Virology 81:47–58
    [Google Scholar]
  32. Schmelz M., Sodeik B., Ericsson M., Wolffe E. J., Shida H., Hiller G., Griffiths G. 1994; Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. Journal of Virology 68:130–147
    [Google Scholar]
  33. Sodeik B. 2000; Mechanisms of viral transport in the cytoplasm. Trends in Microbiology 8:465–472
    [Google Scholar]
  34. Stokes G. V. 1976; High-voltage electron microscope study of the release of vaccinia virus from whole cells. Journal of Virology 18:636–643
    [Google Scholar]
  35. Toomre D., Keller P., White J., Olivo J. C., Simons K. 1999; Dual-color visualization of trans-Golgi network to plasma membrane traffic along microtubules in living cells. Journal of Cell Science 112:21–33
    [Google Scholar]
  36. Wacker I., Kaether C., Kromer A., Migala A., Almers W., Gerdes H. H. 1997; Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein. Journal of Cell Science 110:1453–1463
    [Google Scholar]
  37. Ward B. M., Moss B. 2001; Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein–B5R membrane protein chimera. Journal of Virology 75:4802–4813
    [Google Scholar]
  38. Way M. 1998; Interaction of vaccinia virus with the actin cytoskeleton. Folia Microbiologica 43:305–310
    [Google Scholar]
  39. Wolffe E. J., Katz E., Weisberg A., Moss B. 1997; The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. Journal of Virology 71:3904–3915
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-11-2747
Loading
/content/journal/jgv/10.1099/0022-1317-82-11-2747
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error